ATXN7 antibody (Middle Region)

Catalog No. ABIN927440

Product Details anti-ATXN7 Antibody

Target: ATXN7 (Ataxin 7 (ATXN7))

Binding Specificity: Middle Region

Reactivity: Human, Mouse, Rat, Dog, Chicken

Host: Rabbit

Clonality: Polyclonal

Conjugate: This ATXN7 antibody is un-conjugated

Application: Western Blotting (WB)

Cross-Reactivity: Rat (Rattus), Mouse (Murine), Dog (Canine), Chicken

Purification: Purified

Immunogen: ATXN7 antibody was raised in rabbit using the middle region of ATXN7 as the immunogen

Application Details

Application Notes: WB: 0.2-1 µg/mL
Optimal conditions should be determined by the investigator.

Comment:

ATXN7 Blocking Peptide, catalog no. 33R-9268, is also available for use as a blocking control in assays to test for specificity of this ATXN7 antibody

Restrictions: For Research Use only

Handling

Format: Lyophilized

Concentration: Lot specific

Buffer: Lyophilized powder. Add 50 µL of distilled water. Final antibody concentration is 1 mg/mL in PBS buffer.

Handling Advice: Avoid repeated freeze/thaw cycles.

Storage: 4 °C/-20 °C

Storage Comment: Store at 4 °C, following reconstitution, aliquot and store at -20 °C.

Target Details for ATXN7

Target: ATXN7 (Ataxin 7 (ATXN7))

Alternative Name: ATXN7 (ATXN7 Products)

Background: ATXN7 is involved in neurodegeneration. ATXN7 acts as component of the STAGA transcription coactivator-HAT complex. ATXN7 mediates the interaction of STAGA complex with the CRX and is involved in CRX-dependent gene activation.The autosomal dominant cerebellar ataxias (ADCA) are a heterogeneous group of neurodegenerative disorders characterized by progressive degeneration of the cerebellum, brain stem and spinal cord. Synonyms: Polyclonal ATXN7 antibody, Anti-ATXN7 antibody, ataxin 7 antibody, ADCAII antibody, OPCA3 antibody, SCA7 antibody.